Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Lars Ottosson"'
Autor:
Michael Chau, Zelong Dou, Marta Baroncelli, Ellie B. Landman, Ameya Bendre, Masaru Kanekiyo, Alexandra Gkourogianni, Kevin Barnes, Lars Ottosson, Ola Nilsson
Publikováno v:
npj Regenerative Medicine, Vol 7, Iss 1, Pp 1-17 (2022)
Abstract During the development of the appendicular skeleton, the cartilaginous templates undergo hypertrophic differentiation and remodels into bone, except for the cartilage most adjacent to joint cavities where hypertrophic differentiation and end
Externí odkaz:
https://doaj.org/article/3f71d94abeac49fe917f31549e331a04
Autor:
Huan Yang, Peter Lundbäck, Lars Ottosson, Helena Erlandsson-Harris, Emilie Venereau, Marco E. Bianchi, Yousef Al-Abed, Ulf Andersson, Kevin J. Tracey
Publikováno v:
Molecular Medicine, Vol 27, Iss 1, Pp 1-7 (2021)
Abstract Background High mobility group box 1 (HMGB1) is a nuclear protein with extracellular inflammatory cytokine activity. It is passively released during cell death and secreted by activated cells of many lineages. HMGB1 contains three conserved
Externí odkaz:
https://doaj.org/article/15eb4334e8e64c59a1d86b216d8e0b0f
Autor:
Alexandra Cîrciumaru, Marcelo Gomes Afonso, Heidi Wähämaa, Akilan Krishnamurthy, Monika Hansson, Linda Mathsson-Alm, Márton Keszei, Ragnhild Stålesen, Lars Ottosson, Charlotte de Vries, Miriam A. Shelef, Vivianne Malmström, Lars Klareskog, Anca I. Catrina, Caroline Grönwall, Aase Hensvold, Bence Réthi
Publikováno v:
Biomolecules, Vol 13, Iss 4, p 630 (2023)
Background: Why the adaptive immune system turns against citrullinated antigens in rheumatoid arthritis (RA) and whether anti-citrullinated protein antibodies (ACPAs) contribute to pathogenesis are questions that have triggered intense research, but
Externí odkaz:
https://doaj.org/article/6999994fcf874f858a310c2f18e72d74
Autor:
John D. Lee, Ning Liu, Samantha C. Levin, Lars Ottosson, Ulf Andersson, Helena E. Harris, Trent M. Woodruff
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-12 (2019)
Abstract Background Amyotrophic lateral sclerosis (ALS) is a fatal and rapidly progressing neurodegenerative disease without effective treatment. The receptor for advanced glycation end products (RAGE) and the toll-like receptor (TLR) system are majo
Externí odkaz:
https://doaj.org/article/319c3d8d7ead43eca1b0ce373038d964
Autor:
Zelong Dou, Daniel Muder, Marta Baroncelli, Ameya Bendre, Alexandra Gkourogianni, Lars Ottosson, Torbjörn Vedung, Ola Nilsson
Publikováno v:
Bone Reports, Vol 14, Iss , Pp 101026- (2021)
Externí odkaz:
https://doaj.org/article/e4661225300c425baaa8ff83c1371d57
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100665- (2020)
Externí odkaz:
https://doaj.org/article/c91eaa9c770c414cbd497b333649371d
Autor:
Zelong Dou, Michael Chau, Marta Baroncelli, Ameya Bendre, Ellie Landman, Lars Ottosson, Ola Nilsson
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100410- (2020)
Externí odkaz:
https://doaj.org/article/3848d73f6a1047c99fadf52c2c67cc07
Autor:
Huan Yang, Peter Lundbäck, Lars Ottosson, Helena Erlandsson-Harris, Emilie Venereau, Marco E. Bianchi, Yousef Al-Abed, Ulf Andersson, Kevin J. Tracey, Daniel J. Antoine
Publikováno v:
Molecular Medicine, Vol 26, Iss 1, Pp 1-2 (2020)
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s10020-020-00264-1
Externí odkaz:
https://doaj.org/article/73b477e691924cfdba754831deb07b56
Autor:
Huan Yang, Peter Lundbäck, Lars Ottosson, Helena Erlandsson-Harris, Emilie Venereau, Marco E. Bianchi, Yousef Al-Abed, Ulf Andersson, Kevin J. Tracey, Daniel J. Antoine
Publikováno v:
Molecular Medicine, Vol 26, Iss 1, Pp 1-1 (2020)
Externí odkaz:
https://doaj.org/article/d5ac997d770341debec84f1b55b4573b
Autor:
Trent M. Woodruff, Lars Ottosson, Ning Liu, John D. Lee, Ulf Andersson, Samantha C. Levin, Helena Erlandsson Harris
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-12 (2019)
Background Amyotrophic lateral sclerosis (ALS) is a fatal and rapidly progressing neurodegenerative disease without effective treatment. The receptor for advanced glycation end products (RAGE) and the toll-like receptor (TLR) system are major compone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e58a8e646b351e90eb943025ad4bd64
http://link.springer.com/article/10.1186/s12974-019-1435-2
http://link.springer.com/article/10.1186/s12974-019-1435-2